Shots:
- Bio-Techne has received the European CE-IVD Mark for Ella benchtop immunoassay platform to produce accurate biomarker results in clinical settings
- Ella is compatible with Simple Plex assays powered by R&D Systems antibodies & proteins, offering over 390 analytes across neuroscience, immunology, oncology, & cell & gene therapy to ensure consistent, high-quality data across diverse research applications
- Ella is a compact, cartridge-based immunoassay system that generates accurate biomarker results in under 90 min. with minimal hands-on time, reducing manual variability & delivering high-quality data for translational research & clinical use
Ref: PRnewswire | Image: Bio-Techne | Press Release
Related News: Novocure Receives the US FDA Approval of Optune Pax with CT for Pancreatic Cancer
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
